pregnanolone has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, G; di Michele, F; Longone, P; Luchetti, S; Romeo, E | 1 |
| Esmaeili-Mahani, S; Esmaeilpour, K; Nezhadi, A; Shabani, M; Sheibani, V | 1 |
1 review(s) available for pregnanolone and Parkinson Disease
| Article | Year |
|---|---|
Neurosteroid and neurotransmitter alterations in Parkinson's disease.
Topics: Animals; Basal Ganglia; Brain; Dopamine; Dopaminergic Neurons; Female; GABA-A Receptor Agonists; Humans; Male; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Pregnanolone; Receptors, GABA-A; Substantia Nigra | 2013 |
1 other study(ies) available for pregnanolone and Parkinson Disease
| Article | Year |
|---|---|
Neurosteroid allopregnanolone attenuates cognitive dysfunctions in 6-OHDA-induced rat model of Parkinson's disease.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Cognition Disorders; Disease Models, Animal; Escape Reaction; Exploratory Behavior; Male; Maze Learning; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Pregnanolone; Rats; Rats, Wistar; Reaction Time; Recognition, Psychology; Substantia Nigra | 2016 |